Your feedback matters and will make a difference. Help us understand your digital experience by taking our 10 minute survey. Your responses are completely anonymous. Start the survey.
Document
Link
Clinical commissioning policy: Ustekinumab for refractory Crohn’s disease in pre-pubescent children
NHS England is not responsible for content on external websites.
Summary
Accessible content.
Document
Document
Document
Document
Document
Document